Small Business – The Greenville Advocate

NEW YORK, April 09, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announced the filing of a class action lawsuit on behalf of purchasers of securities of BurgerFi International, Inc. f/k/a Operations Acquisition Corp. (NASDAQ: BFI, OPES) between December 17, 2020 and November 15, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move to Court no later than June 5, 2023.

SO WHAT: If you purchased BurgerFi securities during the Class Period, you may be entitled

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cognyte Software Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 1, 2023

NEW YORK, April 5, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Cognyte Software Ltd..

Shareholders who purchased shares of CGNT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/cognyte-software-ltd-lawsuit-submission-form/?id=38098&from=4

PERIOD CLASS: This lawsuit is on behalf of all purchasers of Cognyte common stock between February 2, 2021 and June 28, 2022inclusive.

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Allianz SE Investors with Losses to Secure Counsel Before Important Deadline in First Filed Securities Class

Published: Feb. 21, 2023 at 1:05 PM CST|Updated: 3 hours ago

NEW YORK, Feb. 21, 2023 /PRNewswire/ —

Rosen Law Firm, PA Logo
Rosen Law Firm, PA Logo(PRNewswire)

WHY: Rosen Law Firm, Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allianz SE (OTC: ALIZY) between March 9, 2018 and May 17, 2022both dates inclusive (the “Class Period”), of the important April 3, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Allianz securities you may be entitled to compensation without payment of any out of pocket fees or costs through a

Traditional and Modern Compensation Models for Law Firms

Law firm compensation models can be complex and difficult to navigate if you’re unfamiliar with them. There is no gold standard and firms typically create their own unique compensation models based on specific formulas and metrics.

Depending on the structure, the topic of a law firm’s compensation model can create an unsettling, competitive environment among partners, lawyers and associates.

Law firm compensation models don’t have to be a sore spot at your firm. Continue reading to learn more about compensation models at law firms and how to structure them to reward individuals fairly.

What are Law

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Invivyd To Contact Him Directly To Discuss

NEW YORK, Feb. 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

If you have suffered losses exceeding $100,000 invest in Invivid stock or options between November 29, 2021 and December 14, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partners Josh Wilson

The Klein Law Firm Announces a Lead Plaintiff Deadline of April 3, 2023 in the Class Action Filed on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.

NEW YORK, Feb. 7, 2023 /PRNewswire/ — The Klein Law Firm announced that a class action complaint has been filed on behalf of shareholders of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD) alleging that the Company violated federal securities laws.

This lawsuit is on behalf of all purchasers of Adagio common stock between November 29, 2021 and December 14, 2021both dates inclusive.
Lead Plaintiff Deadline: April 3, 2023
No obligation or cost to you.

Learn more about your recoverable losses in IVVD:
https://www.kleinstocklaw.com/pslra-1/invivyd-class-action-submission-form?id=36279&from=4

Invivid, Inc. f/k/a Adagio Therapeutics, Inc. NEWS – IVVD NEWS

CLASS ACTION CASE DETAILS:

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sunlight Financial Holdings Inc.

NEW YORK, Jan. 30, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sunlight Financial Holdings Inc. (“Sunlight” or the “Company”) (NYSE: SUNL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Sunlight and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On September 28, 2022Sunlight issued a press release “announc[ing] that an installer liquidity event and volatile interest rates will impact its full-year 2022 financial performance”

Webinar Recap! 2022 Trade Secrets & Non-Competes Year in Review | Seyfarth Shaw

In the second installment of the 2023 Trade Secrets Webinar Series, Seyfarth attorneys reviewed noteworthy legislation, cases, and legal developments from across the nation over the last year in the areas of trade secrets and data theft, non-competes and other restrictive covenants, and computer fraud. Plus, they provided predictions for what to expect in 2023.

As a conclusion to this webinar, we compiled a summary of takeaways:

  • The FTC’s attempted regulation of employment non-competes as part of its rulemaking powers is unprecedented in the 109 years since its creation in 1914. The FTC bases its rulemaking authority on Section 5